Developing New Drugs in 1000 Days

Article

Applied Clinical Trials

August 1, 2002

Applied Clinical Trials

Applied Clinical Trials-08-01-2002

Volume

Developing New Drugs in 1000 Days

Everybody wants faster cycles and and quicker turnarounds with NDAs. In the U.S., will it soon be possible to go from testing to approval in 1000 days?

External Link - article-26825.pdf

Articles in this issue

Cross-(Dys)Functional Teams

Checking In on Children, Checking Up on Files

eSource Redux

New User Fee Program Aims to Spur Drug Development

Developing New Drugs in 1000 Days

Paper vs. Electronic Diaries

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Developing New Drugs in 1000 Days

Newsletter